Chando Global Reports 2024 Profit Plunge: Ranks 7th in Industry with 55% Sales Expense Ratio

Deep News
2025/11/25

Established in 2001, Chando Global Holding Limited has built its reputation on the iconic tagline "You Are Born Beautiful." As a veteran Chinese skincare brand with 24 years of history, Chando maintains strong brand recognition but faces multiple challenges, including delayed IPO plans and over 90% revenue dependency on its core brand.

The company recently submitted its Hong Kong IPO application, with Huatai International and UBS as joint sponsors. Its disclosed financials reveal concerning trends:

1. **Overconcentration Risk & Profit Decline** Chando operates five cosmetic brands, but its flagship "Chando" contributed 94.6%-95.9% of total revenue from 2022 to H1 2025. Other brands collectively accounted for less than 5% during the same period.

The company reported: - 2024 revenue: RMB4.69 billion (+3.6% YoY) - 2024 net profit: RMB190 million (-37.09% YoY) - Gross margin expanded from 66.5% (2022) to 70.1% (H1 2025) - Net profit margin fluctuated between 3.2%-7.8%

Among listed peers, Chando ranked 7th by 2024 revenue (RMB4.66 billion), trailing market leaders like Proya (RMB10.78 billion) and Shanghai Jahwa (RMB6.79 billion).

2. **Heavy Marketing Spend vs Declining R&D** Key expense ratios: - Sales & marketing costs: 55%-59% of revenue - R&D expenditure: Dropped from 2.8% (2022) to 1.7% (H1 2025) of revenue - Administrative expenses: Stable at ~4%

The company employs 2,102 full-time staff, with 49.1% in sales/marketing versus only 7.3% in R&D.

3. **Operational Challenges** Working capital metrics showed mixed trends: - Inventory days improved from 146.6 (2022) to 103.1 (H1 2025) - Trade receivables days remained under 13 days - Trade payables hovered around RMB0.9-1.06 billion - Operating cash flow turned positive after 2022's RMB295 million outflow

Liquidity ratios stayed stable with current ratio at 1.0 and quick ratio at 0.7 as of H1 2025. Cash reserves grew to RMB931 million by mid-2025.

The controlling Zheng family holds 87.82% voting rights. IPO proceeds will fund DTC expansion, multi-brand development, overseas growth, and digital transformation.

Consumer complaints (605 recorded on Hei Mao platform) primarily cite service quality, refund issues, and product claims. The company's ability to balance marketing efficiency with product innovation will be critical for its post-IPO performance.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10